Maxidex (dexamethasone): Side Effects, Dosage & Warnings

Maxidex (dexamethasone) ophthalmic suspension 0.1% is an adrenocortical steroid used for:

steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva,
cornea,
and anterior segment of the globe such as allergic conjunctivitis,
acne rosacea,
superficial punctate keratitis,
herpes zoster keratitis,
iritis,
cyclitis,
selected infective conjunctivitides when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation;
corneal injury from chemical,
radiation,
or thermal burns,
or penetration of foreign bodies.

Common side effects of Maxidex include:

SHAKE WELL BEFORE USING.
One or two drops topically in the
conjunctival sac(s).
In severe disease, drops may be used hourly, being tapered to discontinuation as the inflammation subsides.
In mild disease, drops may be used up to four to six times daily.

No Information Provided

Maxidex (dexamethasone ophthalmic suspension) should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the embryo or fetus.
There are no adequate or well-controlled studies in pregnant women. However, prolonged or repeated corticoid use during pregnancy has been associated with an increased risk of intra-uterine growth retardation.
Infants born of mothers who have received substantial doses of corticosteroids during pregnancy should be observed carefully for signs of hypoadrenalism.
Systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects. It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in human milk.
Because many drugs are excreted in human milk, caution should be
exercised when Maxidex (dexamethasone ophthalmic suspension) is administered to a nursing woman.